MedPath

Impact of pharmacokinetics of Cabozantinib on clinical response and adverse event in patients with hepatocellular carcinoma

Not Applicable
Recruiting
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000043775
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Patients regarded as inappropriate subject

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath